Poltreg SA

Poltreg SA maintains a strong liquidity position, with cash and equivalents amounting to 45.76 million PLN, representing 38.7% of total assets. The company's liquidity FPT (free cash flow to total assets) is negative at -8.9%, indicating ongoing cash outflows from operations. The current ratio of 4.94 suggests the company has sufficient short-term assets to cover its liabilities multiple times over.

Profitability metrics are negative, with a return on equity of -3.98% and a return on assets of -2.84%. These figures indicate that the company is not generating returns for shareholders or effectively utilizing its assets. The gross profit of -1.95 million PLN and operating income of -3.82 million PLN further underscore the company's unprofitable operations.

Geographically, Poltreg SA's revenue is concentrated in a single jurisdiction, as disclosed revenue is reported without segment breakdown. This lack of diversification increases exposure to local economic and regulatory risks. The company's revenue of 100 million PLN is derived from a single revenue stream, with no disclosed geographic or product diversification.

The company's growth trajectory is uncertain, with no disclosed revenue growth or decline in the most recent period. Analysts have assigned a mean price target of 67.30 PLN, with a single "buy" recommendation and no "strong buy" or "hold" ratings. The absence of analyst optimism suggests limited confidence in the company's near-term performance.

Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The company's debt-to-equity ratio of 0.1 indicates a conservative capital structure, with long-term debt at 8.01 million PLN and total equity at 84.28 million PLN. No dilution sources were identified in recent filings, and the dilution potential is assessed as low.

Recent events include the publication of the latest financial results, which show continued losses and negative cash flows. No material regulatory or litigation events were disclosed in the most recent filings. The company's capital expenditure of -7.44 million PLN reflects ongoing investment in operations, but the negative free cash flow of -10.52 million PLN indicates that these investments are not yet generating positive returns.

Analysts project 247.8% upside to a target price of 67.3 PLN, significantly above the current market price of 19.35 PLN.

Cash conversion ratio of 0.9 exceeds the cohort median of 0.87, suggesting superior ability to convert earnings into cash.

Debt-to-equity ratio of 0.1 is below the cohort median of 0.02, reflecting a conservative leverage position relative to peers.

Long-term debt decreased from 8.19 million PLN in FY2024 to 7.62 million PLN in FY2026, showing a trend of debt reduction.

Revenue collapsed to zero in FY2026, down from 350,000 PLN in FY2025, indicating a complete cessation of top-line generation.

Net losses widened to 26.0 million PLN in FY2026, up from 18.7 million PLN in FY2025, demonstrating deteriorating profitability.

Operating margin of -38.19% places the company in the bottom quartile of the biotechnology cohort, signaling severe operational inefficiency.

The company carries a high credit risk flag, suggesting significant concerns regarding its ability to meet financial obligations.

Free cash flow remained deeply negative at -20.9 million PLN in FY2026, highlighting persistent cash burn despite revenue collapse.

Revenue PLN 0.00; Operating income −23,4% YoY.

• ▍Revenue PLN 0.00
• ▍Operating income −23,4% YoY
• ▍Net income −31,7% YoY
• ▍Free cash flow −41,9% YoY

Revenue PLN 0.00, −100,0% YoY; Operating income +3,8% YoY.

• ▍Revenue PLN 0.00, −100,0% YoY
• ▍Operating income +3,8% YoY
• ▍Net income −3,1% YoY
• ▍Free cash flow −3,6% YoY

Revenue PLN 0.00; Operating income −59,2% YoY.

• ▍Revenue PLN 0.00
• ▍Operating income −59,2% YoY
• ▍Net income −71,8% YoY
• ▍Free cash flow −46,7% YoY

Revenue PLN 0.00, −100,0% YoY; Operating income −49,3% YoY.

• ▍Revenue PLN 0.00, −100,0% YoY
• ▍Operating income −49,3% YoY
• ▍Net income −63,3% YoY
• ▍Free cash flow +61,3% YoY

Revenue PLN 0.00; Operating income -PLN 4.8M.

• ▍Revenue PLN 0.00
• ▍Operating income -PLN 4.8M

Revenue PLN 250.0k; Operating income -PLN 6.3M.

• ▍Revenue PLN 250.0k
• ▍Operating income -PLN 6.3M
• ▍Net margin -2352.4%

Revenue PLN 0.00; Operating income -PLN 5.3M.

• ▍Revenue PLN 0.00
• ▍Operating income -PLN 5.3M

Revenue PLN 100.0k; Operating income -PLN 3.8M.

• ▍Revenue PLN 100.0k
• ▍Operating income -PLN 3.8M
• ▍Net margin -3351.0%

Revenue PLN 0.00, −100,0% YoY; Operating income −29,2% YoY.

• ▍Revenue PLN 0.00, −100,0% YoY
• ▍Operating income −29,2% YoY
• ▍Net income −39,0% YoY
• ▍Free cash flow +11,0% YoY

Revenue PLN 350.0k, −75,0% YoY; Operating income −20,3% YoY.

• ▍Revenue PLN 350.0k, −75,0% YoY
• ▍Operating income −20,3% YoY
• ▍Net income −38,1% YoY
• ▍Free cash flow +46,8% YoY
• ▍Net margin -5345.1%

Revenue PLN 1.4M, +40,0% YoY; Operating income −222,3% YoY.

• ▍Revenue PLN 1.4M, +40,0% YoY
• ▍Operating income −222,3% YoY
• ▍Net income −588,9% YoY
• ▍Free cash flow −405,0% YoY
• ▍Net margin -968.6%